Membership Event 31 January 12.30 to 3pm
Welcome
Agenda for today Time What Who? 1pm Welcome and update Dr Anuj Patel Chair, Barnet Federated GPs 1.15pm Clinical pharmacists in general practice Amit Patel Chief Operating Officer, Barnet Federated GPs NHS England clinical pharmacist programme Experience from a wave one clinical pharmacist David Tamby Rajah in a Barnet practice Head of Community Pharmacy Contracts, NHS Questions and answers England Dr Latha Reddy GP, St Andrews Medical Practice 1.45pm Our three year business plan Dr Anuj Patel Chair, Barnet Federated GPs Highlights from three year business plan Investment proposal for members Amit Patel Questions and answers Chief Operating Officer, Barnet Federated GPs 2.55pm Summary and close Dr Anuj Patel Chair, Barnet Federated GPs
Our board Dr Sanjiv Ahluwalia Strategic adviser
Chair’s update Business Plan • Our three year strategy • Investment proposal Building our internal infrastructure • Governance structures • Chief Operating Officer recruitment • Business manager recruitment • Project manager recruitment Collaborative working • Developing our CHINs (Care Closer to Home Integrated Networks) • North London Partners – primary care strategy development Pipeline services • MSK / Urology / Gynae / paediatric QIST
Communications & engagement update Communications • Newsletter • Website update - www.barnetfederatedgps.org.uk • Practice logins • Linking with CEPN and PPGs
Communications & engagement update 7
Service updates Current services • Enhanced service • GP Streaming • DQIST (Diabetes Quality Improvement Service)
Shared resource update Shared resource • Bluestream Academy - training • Practice Managers Learning Group (PMLG) • Barnet policy bank
Any questions?
Clinical pharmacists in general practice Speakers Amit Patel Chief Operating Officer, Barnet Federated GPs David Tamby Rajah Head of Community Pharmacy Contracts, NHS England Dr Latha Reddy GP, St Andrews Medical Practice
General Practice Forward View Update : Clinical Pharmacists in GP Practices. Barnet Update.
Progress Key headlines The London Region 3 year target is 252 WTE Pharmacists (CPs) or 84 WTE/pa over 3 years. Application Wave No. CP No. of No. GP Combined Practice WTE approved Practices Population Size Approvals Applications Wave 1 – Mar 17 45.45 11 177 1,452,781 Wave 2 – Jun 17 81.10 14 342 2,464,554 Wave 3 – Nov 17 27.00 4 115 807,107 60% of the 3 year target has been allocated between March to December 2017. Recruitment Progress This will be a key priority to monitor in 2018 Wave 1 and 2 approved sites are now deploying through 25 applications with wave 3 applications recently approved in December 2017. • 10.3 WTE pharmacists are now in post as of the end of December 2017 • 10.8 WTE pharmacists are expected to be in post by the end of February 2018 13
Next steps Waves 1 – 3 approved sites now being implemented Service model - Contracting model will be via a GP enhanced service. Service payments • National allocation to regional teams • Payments vis CQRS method of payment one month in arears. (process being updated and not deployed yet) • Interim – allocation from National team to the regional team to allocate to applicants Recruitment – all approved sites will be now monitored on recruitment Training & education • Health Education England has recently completed a procurement exercise for a training and development pathway for clinical pharmacists. • The Independent Prescribing training procurement and practice development procurement is still in progress. • In practice support for Gps. 14
GP 5 year forward view next steps Source documents 2016 Murray review- T he Independent Review of Community Pharmacy Clinical Services commissioned by the Chief Pharmaceutical Officer of NHS England in April 2016 to help inform him about the future provision of clinical pharmacy services. NHS England intended to use the recommendations of the independent review to inform its approach to the commissioning of NHS community pharmacy services once the review recommendations have been properly considered. To date nothing has happened nationally. London region can draw useful leanings from this report. https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2016/12/community-pharm-clncl- serv-rev.pdf 2016 PSNC Pharmacy 5 year forward view - Community Pharmacy Forward View- This was published by 3 community pharmacy stakeholder organisations (PSNC , Pharmacy Voice, with the support of the RPS English Pharmacy Board), on 30th August 20160 This report sets out the pharmacy sector’s ambitions to radically enhance and expand the personalised care, support and wellbeing services that community pharmacies provide. Community pharmacy teams would be fully integrated with other local health and care services in order to improve quality and access for patients, increase NHS efficiency and produce better health outcomes for all.. http://psnc.org.uk/services-commissioning/community-pharmacy-forward-view/ There is focus on 3 roles that community pharmacy could deliver. 1. Community pharmacy as the facilitator of personalised care for people with long-term conditions. 2. As the trusted, convenient first port of call for episodic healthcare advice and treatment. 3. As the neighbourhood health and wellbeing hub. 15
Workload challenges within General Practice Improve Medicines Management Opportunity to innovate & collaborate Standardise practice across 3 GP sites NHSE Wave 1 Pilot
Medication Reviews Prescription Queries Polypharmacy/Dosette Box Reviews Meds Reconciliation post hospital discharge Liaising with patients/secondary care/CP Long Term Condition reviews – HTN, Asthma Relevant Workflow/document management Review of Prescribing Protocol MHRA Actions
Supportive environment LNA/CPD/Mentorship Induction; 3m high intensity support/daily debriefs Designated clinical support thereafter Consolidating/Understanding existing skills Mutual understanding of practice roles Balance between training and service provision
Role Development Telephone Triage Minor Illness Clinics Patient Education Groups Advanced Long Term Conditions Management Audits
Reduction in GP workload Appropriate workload displacement from GPs Timely medicines reconciliation Improved safety Collaborative working – shared training
Balance between training and service provision Understanding remit and limits of role Identifying strengths and weaknesses Effective, efficient use of a valuable resource
Our three year business plan Speakers Dr Anuj Patel Chair, Barnet Federated GPs Amit Patel Chief Operating Officer, Barnet Federated GPs
Overview Barnet Federated GPs • Formed in 2016, Barnet Federated GPs is a collaboration of all 60 NHS GP practices in the London Borough of Barnet. • Care Quality Commission (CQC) registered provider organisation. • Following members vote, our organisational is a Community Interest Company (CIC). • Five board members, a chief operating officer and strategic adviser. More appointments to follow. 26
Our business plan 2018 to 2021 Our business plan 2018 to 2021 • Full business case and summary developed • Commercial and in confidence for senior GPs and practice managers • Non-confidential versions will be available on website Barnetfederatedgps.org.uk 27
Our business plan 2018 to 2021 The plan sets out: • Our vision, values and principals – and how we will achieve them • Local and national picture for primary care • Achievements so far • Your challenges and how we will support you • Plan for the next three years • Time line • Your investment 28
Our business plan 2018 to 2021 29
Our business plan 2018 to 2021 Strengths of Barnet Federated GPs 30
Our business plan 2018 to 2021 31
Our business plan 2018 to 2021 32
Our business plan 2018 to 2021 Overview of three year plan 33
Our business plan 2018 to 2021 34
Our business plan 2018 to 2021 35
Our business plan 2018 to 2021 36
Our business plan 2018 to 2021 Option A Shareholder investor • Have voting rights • Receive the annual report and invited to attend the annual general meeting • Full access to shared resource offer • Provider status for the delivery of services that the federation has secured • Access to any future dividends of the company. 37
Our business plan 2018 to 2021 Option B Shareholder only • Have voting rights • Receive the annual report and be invited to attend the annual general meeting. No other benefits would be accrued to practices with shareholder only status. Under option B, practices would be asked to purchase a single share at the cost of £1 per share (one share per practice) 38
Any questions?
Next steps March 2018: Practices return Early Feb: Letter End of Feb: signed to practices to Shareholder April 2018: shareholder confirm preferred agreement sent to Membership event agreement and membership practices for to launch new CIC confirm investment option completion payment schedule (if applicable) Next membership meeting: TBC April 2018 40
Recommend
More recommend
